InsidersTradesSigma
Browse the complete record of transactions filed by Tovey Christopher J., Chief Executive Officer. Officer active across 2 companies, notably GW Pharmaceuticals PLC. Cumulatively, 6 disclosures have been published. The latest transaction was disclosed on 5 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
6 of 6 declarations
Christopher J. Tovey is the Chief Operating Officer and Executive Vice President at GW Pharmaceuticals PLC and Jazz Pharmaceuticals plc. In this role, he oversees the daily operations of the company and contributes to the overall strategy. His expertise in the pharmaceutical industry is an asset to both firms.